Government Doctors Are Not Allowed Private Practice: Health Ministry

NEW DELHI: As per Central Health Service (CHS) Rules, 2014, persons appointed to CHS shall not be allowed private practice of any kind whatsoever including any consultation and laboratory practice, according to the Ministry of Health. The ministry also informed the lower house today that doctors are entitled to a Non-Practicing Allowance (NPA) of 20% of Basic Pay subject to the condition that the Basic Pay plus NPA does not exceed Rs., 2,37,500/- after acceptance of the recommendations of the Seventh Central Pay Commission.

The Minister of State (Health and Family Welfare), Ashwini Kumar Choubey also stated in a written reply in the Lok Sabha here today that as and when any instance of private practice is brought to the notice of the Government, appropriate action is taken in the matter as per rules and procedure of the Government.

“As far as Central Government is concerned, as per Rule 13 of Central Health Service (CHS) Rules, 2014, persons appointed to CHS shall not be allowed private practice of any kind whatsoever including any consultation and laboratory practice,” the minister said.

“In lieu of private practice, doctors are entitled to a Non-Practicing Allowance (NPA) of 20% of Basic Pay subject to the condition that the Basic Pay plus NPA does not exceed Rs., 2,37,500/- after acceptance of the recommendations of the Seventh Central Pay Commission,” he added.

“Health being a State subject”, the minister also said, “no such information in respect of State Government Hospitals is maintained centrally”.

Related Posts

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

New Delhi: Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research and development activities with the business representatives of the pharmaceutical industry. “Had…

Senores Pharma to Buy Two Teva ANDAs

Mumbai, August 14, 2025 — Senores Pharmaceuticals will acquire two abbreviated new drug applications (ANDAs) from Teva Pharmaceuticals USA. The deal is Senores’ third US move in six months, underscoring…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Senores Pharma to Buy Two Teva ANDAs

Senores Pharma to Buy Two Teva ANDAs

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lilly launches Mounjaro KwikPen in India

Lilly launches Mounjaro KwikPen in India